Not pretreated for Muscle Pain

"The clinical trial is currently looking for patients, as indicated by the information on clinicaltrials.gov. This trial was first posted on October 2nd, 2020 and was last updated on September 6th, 2022."

"The medical procedures of intubation, general anesthesia, and tracheal intubation can be facilitated by administering Pre-treatment 2 minutes before succinylcholine."

"Eligibility requirements for this trial include myalgia and being between 18-100 years old. A total of 300 patients are needed for this study."

"According to the eligibility requirements published for this trial, patients between the ages of 18 and 100 may participate. There are 10 separate trials for patients younger than 18 and 27 trials for patients that are 65 or older."

"That is accurate. The information available on clinicaltrials.gov tells us that this clinical trial is looking for volunteers right now. The listing was first created on October 2nd, 2020 and was updated September 6th, 2022. They need 300 individuals total and are only testing at a single site."

"Currently, there are 16 clinical trials underway investigating the use of Pre-treated 2 minutes before succinylcholine administratjion. 3 of those trials are in Phase 3. The majority of trials for Pre-treated 2 minutes before succinylcholine administratjion are based in Montreal, Quebec, but there are 29 locations running studies for this treatment."

"This study has reached Phase 3, meaning that there is both evidence of efficacy and multiple rounds of data supporting safety. As such, we have rated the safety of Pre-treated 2 minutes before succinylcholine administratjion as a 3."

"Pre-treatment with 2 minutes of administration of succinylcholine has been studied since 2009. The first study was sponsored by Medtronic - MITG and occurred in 80 patients. After the first trial, Pre-treatment with 2 minutes of administration of succinylcholine received N/A drug approval. There are 16 live trials today for Pre-treatment with 2 minutes of administration of succinylcholine across 11 cities and 10 countries."